Gainers to Watch - MGIC Investment Corp. (NYSE:MTG), Himax Technologies (NASDAQ:HIMX), Cree, Inc. (NASDAQ:CREE), Acura Pharmaceuticals

New York, NY -- (SBWIRE) -- 03/06/2013 -- Alpha Penny Stock knows Hot stocks, especially hot Small and Mid Capstocks, and knows that The RIGHT Stock can offer the HIGHEST percentage gains of any stocks in the market. At AlphaPennyStock, we highlight and alert on the best penny stocks and value investments in stocks on any stock market. The stock picks issued at AlphaPennyStock are the top penny stocks that we are evaluating for the best return on investment.

MGIC Investment Corp. (NYSE:MTG) shares gained after it declared that it is selling 135 million common shares and $350 million in convertible notes to increase capital. The stock sale would generate almost $721 million. Further grants to underwriters would put the total amount raised around $1.2 billion.

In the last trading session, MGIC Investment Corp. (NYSE:MTG)reported the gain of +27.75% and closed at $5.34 with the overall traded volume of 60.80 million shares. MTG has market cap of 1.08 billion.

For How Long MTG will Fight for Profitability? Read This Trend Analysis report

Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) surged +18.02% with the closing price of $4.06. The overall volume in the last trading session was 18.27 million shares. Its fifty two week range was $1.47-$4.79. The total market capitalization remained $688.47million.

HIMX is ahead its 52 week low with 176.19% and its last month price volatility remained 11.42%. Its beta coefficient was 1.63 with a target price of $3.80. HIMX has insider ownership of 12.38% with its institutional ownership remained 14.31%. Company’s current year earnings per share grew with 395.70% while the five year EPS growth rate was 12.05%.

For How Long HIMX’s Gloss will Attract Investors? Find out via this report

Cree, Inc. (NASDAQ:CREE) shares moved up and touched a new high of $52.35 after it raised its adjusted earnings guidance for the third quarter to a range of $0.31 to $0.36 per share from the earlier forecast in the $0.30 to $0.35 per share range. The company also raised its third-quarter revenue guidance to a range of $335 million to $350 million from the prior estimate between $325 million and $345 million.

In the last trading session, Cree, Inc. (NASDAQ:CREE) gained +14.40% to close at $51.16 and its total traded volume was 13.28 million shares more than the average volume of 2.49 million.

Will CREE Continue To Move Higher? Find Out Here

Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) shares went up +48.29% and closed at $3.04 in the last trading session with the total traded volume of 8.64 million shares. ACUR has market cap of 139.43 million and its beta value stands at 0.85 times. Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development and commercialization of products focused on addressing medication abuse and misuse, utilizing its Aversion and Impede Technologies.

Why Should Investors Buy ACUR After The Recent Gain? Just Go Here and Find Out

About Alpha Penny Stock
Alphapennystock.co m is an Independent Company, our focus is on small cap stocks that trade on OTCBB and OTC markets, and are mostly referred to as “penny stocks”. These are stocks that normally trade under $5 a share and could offer the greatest potential return on your short or long term investment. We strive to live up to our name, Alpha, being the leader in the industry. It is important to understand that these stocks also carry high risk. You must read our Disclaimer page for more information regarding conflicts of interest and the risks involved.

We try to spot stocks in all types of market conditions. In addition, we provide emerging small cap companies with profiling and investor relations services for compensation. If you believe your company is an emerging company, with a solid product, or a company that offers our members a profitable short or long term opportunity please feel free to send us an e-mail and we’ll review the company and reply to your inquiry promptly. Please provide as much information you believe we’ll need to review your request.